The effects of dyslipidemia on left ventricular systolic function in patients with stable angina pectoris

Atherosclerosis

Volumn 146, Issue 1, 1999, Pages 117-124

  Wang, Tzung Dau ^a,b   Lee, Chii Ming ^b   Wu, Chau Chung ^b   Lee, Tsung Ming ^b   Chen, Wen Jone ^b   Chen, Ming Fong ^b   Liau, Chiau Suong ^b   Sung, Fung Chang ^c   Lee, Yuan Teh ^b  

^a EN CHU KONG HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cholesterol; Coronary disease; Ejection fraction

Indexed keywords

ACETYLSALICYLIC ACID; APOLIPOPROTEIN A1; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC ACID DERIVATIVE; SIMVASTATIN; THALLIUM 201; TRIACYLGLYCEROL;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; DYSLIPIDEMIA; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE PERFORMANCE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; ANALYSIS OF VARIANCE; ANGINA PECTORIS; CORONARY ARTERIOSCLEROSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART CATHETERIZATION; HUMANS; HYPERLIPIDEMIAS; LINEAR MODELS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; SYSTOLE; TAIWAN; VENTRICULAR FUNCTION, LEFT;

EID: 0032779878     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00108-2     Document Type: Article

References (36)

1. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering therapy in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
2. Shepherd J, Cobbe SM, Isles CG, Lorimer AR, MacFarlane PN, Mckillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. The West of Scotland Coronary Prevention Study Group. New Engl J Med 1995;333:1301-7.
3. Jenkins GH, Grieve LA, Yacoub MH, Singer DRJ. Effect of Simvastatin on ejection fraction in cardiac transplant recipients. Am J Cardiol 1996;78:1453-6.
4. Lars Bastiaanse EM, Atsma DE, Kuijpers MMC, Van der Laarse A. The effect of sarcolemmal cholesterol content on intracellular calcium ion concentration in cultured cardiomyocytes. Arch Biochem Biophys 1994;313:58-63.
5. Liu K, Massaeli H, Pierce GN. The action of oxidized low-density lipoprotein on calcium transients in isolated rabbit cardiomyocytes. J Biol Chem 1993;268:4145-51.
6. Wang TD, Wu CC, Chen WJ, Lee CM, Chen MF, Liau CS, Sung FC, Lee YT. Dyslipidemias have a detrimental effect on left ventricular systolic function in patients with a first myocardial infarction. Am J Cardiol 1998;81:531-7.
7. Kempen HJ, Van Gent CM, Buytenhek R, Buis B. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function. J Lab Clin Med 1987;109:19-26.
8. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1983;28:1039-1057.
9. Allain LA, Poon LS, Chan LSG, Richmond W, Fu PL. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
10. McGowan MW, Artiss JD, Strandbergh DR, Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 1983;29:538-42.
11. Buege JA, Aust SD. Microsomal lipid peroxidation methods. Enzymology 1978;52:302.
12. Rifani N, Silverman LM. A simple immunotechnique for the determination of serum concentration of apolipoprotein E. Clin Chim Acta 1987;163:207-13.
13. Fless GM, Snyer ML, Scanu AM. Enzyme-linked immunoassay for Lipoprotein (a). J Lipid Res 1989;30:651-2.
14. Judkins MP. Selective coronary arteriography, part I: a percutaneous transfemoral approach. Radiology 1967;89:815-9.
15. Gensini G. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51:606.
16. Lauer MS, Evans JC, Levy D. Prognostic implications of sub-clinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study). Am J Cardiol 1992;70:1180-4.
17. Ross J Jr. Myocardial perfusion-contraction matching: implications for coronary heart disease and hibernation. Circulation 1991;83:1076-83.
18. Lewis SJ, Sawada SG, Ryan T, Segar DS, Armstrong WF, Feigenbaum H. Segmental wall motion abnormalities in the absence of clinically documented myocardial infarction: clinical significance and evidence of hibernating myocardium. Am Heart J 1991;121:1088-94.
19. Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative planar rest-redistribution 201 Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993;87:1630-41.
20. National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation 1994;89:1333-1445.
21. Grundy SM, Goodman DS, Rifkind BM. The place of HDL in cholesterol management: A perspective from the National Cholesterol Education Program. Arch Intern Med 1989;149:505-10.
22. Lien WP, Lai LP, Shyu KG, Hwang JJ, Chen JJ, Lei MH, Cheng JJ, Huang PJ, Tsai KS. Low-serum high-density lipoprotein cholesterol concentration is an important coronary risk factor in Chinese patients with low serum levels of total cholesterol and triglyceride. Am J Cardiol 1996;77:1112-5.
23. Chen Z, Peto R, Collins R, MacMahon S, Lu J, Li W. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. Br Med J 1991;303:276-82.
24. Cannon RO, Epstein SE. Microvascular angina as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 1988;61:1338-43.
25. Motz W, Wogt M, Rabenan O, Scheler S, Luckhoff A, Strauer BE. Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary angiograms. Am J Cardiol 1991;68:996-1003.
26. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. New Engl J Med 1993;328:1659-64.
27. Hessler JR, Robertson AL Jr, Chisolm GM III. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 1979;32:213-9.
28. Matsuda Y, Hirata KI, Inoue N, Suematsu M, Kawashima S, Akita H, et al. High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation. Cire Res 1993;72:1103-9.
29. Reaven GM. Role of insulin resistance in human disease (syndrome X): An expanded definition. Annu Rev Med 1993;44:121-31.
30. Steinberg HO, Brechtel G, Johnson A. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. J Clin Invest 1994;94:1172-9.
31. Chauhan A, Foote J, Petch MC, Schofield PM. Hyperinsulinemia, coronary artery disease and syndrome X. J Am Coll Cardiol 1994;23:364-8.
32. Stimpel M, Neyses L, Locher R, Knorr M, Vetter W. High-density lipoprotein-modulators of the calcium channel? J Hypertens 1986;3(Suppl 3):49-51.
33. Mintz GS, Painter JA, Pichard AD, Kent KM, Satler LF, Popma JJ, Chuang YC, Bucher TA, Sokolowicz LE, Leon MB. Atherosclerosis in angiographically normal coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol 1995;25:1479-85.
34. Zarich SW, Nesto RW. Diabetic cardiomyopathy. Am Heart J 1989;118:1000-12.
35. Pollare T, Lithell H, Selinus I, Berne C. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double-blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. Br Med J 1989;298:1152-7.
36. Keil U, Kuulasmaa K. The WHO MONICA project: risk factors. Int J Epidemiol 1989;18(Suppl 1):46-55.